APA (7th ed.) Citation

Kivrak, M., Nalkiran, I., & Nalkiran, H. S. Exploring the Therapeutic Potential of the DOT1L Inhibitor EPZ004777 Using Bioinformatics and Molecular Docking Approaches in Acute Myeloid Leukemia. MDPI AG.

Chicago Style (17th ed.) Citation

Kivrak, Mehmet, Ihsan Nalkiran, and Hatice Sevim Nalkiran. Exploring the Therapeutic Potential of the DOT1L Inhibitor EPZ004777 Using Bioinformatics and Molecular Docking Approaches in Acute Myeloid Leukemia. MDPI AG.

MLA (9th ed.) Citation

Kivrak, Mehmet, et al. Exploring the Therapeutic Potential of the DOT1L Inhibitor EPZ004777 Using Bioinformatics and Molecular Docking Approaches in Acute Myeloid Leukemia. MDPI AG.